Maven Capital Partners expands EIS offering with acquisition of Newable Ventures

Mattioli Woods subsidiary

Cristian Angeloni
clock • 1 min read

Mattioli Woods subsidiary Maven Capital Partners has acquired EIS fund manager Newable Ventures for an undisclosed sum.

Newable is part of the Newable Capital Group and has £12m in assets under management. The acquisition will boost Maven's plans to expand its activities into direct Enterprise Investment Scheme investments. Autumn Statement 23: VCT and EIS sunset clauses extended by a decade In a stock exchange notice today (1 December), Mattioli Woods said the deal represented a "strategic milestone" for Maven by providing emerging businesses with an additional way to access capital, as well as a tax-efficient avenue for clients to invest in smaller UK companies with high growth potential. Bill Nix...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Companies

ARC launches MPS indices to 'give IFAs clarity'

ARC launches MPS indices to 'give IFAs clarity'

IFAs to have free access to the index series

Isabel Baxter
clock 31 January 2025 • 2 min read
SJP posts record FUM in 2024 despite fall in net flows

SJP posts record FUM in 2024 despite fall in net flows

£5.5bn in new client investments

Beth Brearley
clock 30 January 2025 • 2 min read
Martin Currie to be absorbed into ClearBridge Investments brand

Martin Currie to be absorbed into ClearBridge Investments brand

Subject to regulatory approvals

Cristian Angeloni
clock 29 January 2025 • 1 min read
Trustpilot